Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07029-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Di Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Monoclonal, Humanized, Cholesterol, HDL, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
- Department of Rheumatology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China. oliviadd1020@sina.cn.
Zitieren
APA
Liang, D., Huang, S., & Ding, R. (2024). Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07029-9
Vancouver
Liang D, Huang S, Ding R. Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07029-9
BibTeX
@article{Liang2024,
author = {Liang, Di and Huang, Shimei and Ding, Rui},
title = {Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07029-9}
}
EUVIMED